BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williams SC. New biologic drugs get under the skin of psoriasis. Nat Med. 2012;18:638. [PMID: 22561807 DOI: 10.1038/nm0512-638] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Filkor K, Hegedűs Z, Szász A, Tubak V, Kemény L, Kondorosi É, Nagy I. Genome wide transcriptome analysis of dendritic cells identifies genes with altered expression in psoriasis. PLoS One 2013;8:e73435. [PMID: 24039940 DOI: 10.1371/journal.pone.0073435] [Reference Citation Analysis]
2 Ports WC, Khan S, Lan S, Lamba M, Bolduc C, Bissonnette R, Papp K. A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. Br J Dermatol 2013;169:137-45. [PMID: 23387374 DOI: 10.1111/bjd.12266] [Cited by in Crossref: 136] [Cited by in F6Publishing: 100] [Article Influence: 19.4] [Reference Citation Analysis]
3 Truchetet ME, Mossalayi MD, Boniface K. IL-17 in the rheumatologist's line of sight. Biomed Res Int 2013;2013:295132. [PMID: 23984335 DOI: 10.1155/2013/295132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang Z, Zheng H, Zhou H, Huang N, Wei X, Liu X, Teng X, Hu Z, Zhang J, Zhou X, Li W, Li J. Systematic screening and identification of novel psoriasis‑specific genes from the transcriptome of psoriasis‑like keratinocytes. Mol Med Rep 2019;19:1529-42. [PMID: 30592269 DOI: 10.3892/mmr.2018.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gessi S, Merighi S, Borea PA. Targeting adenosine receptors to prevent inflammatory skin diseases. Exp Dermatol 2014;23:553-4. [PMID: 24961687 DOI: 10.1111/exd.12474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
6 Enyedy IJ, Powell NA, Caravella J, van Vloten K, Chao J, Banerjee D, Marcotte D, Silvian L, McKenzie A, Hong VS, Fontenot JD. Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorg Med Chem Lett 2016;26:2459-63. [PMID: 27080181 DOI: 10.1016/j.bmcl.2016.03.109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
7 Filkor K, Hegedűs Z, Szász A, Tubak V, Kemény L, Kondorosi É, Nagy I. Genome wide transcriptome analysis of dendritic cells identifies genes with altered expression in psoriasis. PLoS One 2013;8:e73435. [PMID: 24039940 DOI: 10.1371/journal.pone.0073435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
8 Andrés RM, Montesinos MC, Navalón P, Payá M, Terencio MC. NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. J Invest Dermatol 2013;133:2362-71. [PMID: 23594598 DOI: 10.1038/jid.2013.182] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
9 Tang L, He S, Wang X, Liu H, Zhu Y, Feng B, Su Z, Zhu W, Liu B, Xu F, Li C, Zhao J, Zheng X, Lu C, Zheng G. Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3. Exp Dermatol 2018;27:268-75. [DOI: 10.1111/exd.13511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Williams SCP. Flurry of deal-making surrounds new autoimmunity target. Nat Med 2013;19:1078-1078. [DOI: 10.1038/nm0913-1078a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
11 Boniface K. Role of Th17 cells in the pathogenesis of rheumatoid arthritis. WJR 2013;3:25. [DOI: 10.5499/wjr.v3.i3.25] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Arasa J, Martos P, Terencio MC, Valcuende-cavero F, Montesinos MC. Topical application of the adenosine A 2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice. Exp Dermatol 2014;23:555-60. [DOI: 10.1111/exd.12461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
13 Szász A, Strifler G, Vörös A, Váczi B, Tubak V, Puskás LG, Belső N, Kemény L, Nagy I. The expression of TAM receptors and their ligand Gas6 is downregulated in psoriasis. J Dermatol Sci 2013;71:215-6. [PMID: 23684948 DOI: 10.1016/j.jdermsci.2013.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Andrés RM, Payá M, Montesinos MC, Ubeda A, Navalón P, Herrero M, Vergés J, Terencio MC. Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes. Pharmacological Research 2013;70:20-6. [DOI: 10.1016/j.phrs.2012.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
15 Hamilton JA, Achuthan A. Colony stimulating factors and myeloid cell biology in health and disease. Trends in Immunology 2013;34:81-9. [DOI: 10.1016/j.it.2012.08.006] [Cited by in Crossref: 159] [Cited by in F6Publishing: 151] [Article Influence: 19.9] [Reference Citation Analysis]